We are looking for children 2–17 years of age to join a CD clinical research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s disease (including associated symptoms such as tiredness, reduced appetite, rectal pain, chronic fatigue and/or joint pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
